Full Name
Raghav Sundar
(not current staff)
 
 
Email
mdcragh@nus.edu.sg
 
 

Publications

Results 21-28 of 28 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
212017Limb hypothermia for preventing paclitaxel-induced peripheral neuropathy in breast cancer patients: A pilot studySundar, R ; Bandla, A ; Tan, S.S.H ; Liao, L.-D ; Kumarakulasinghe, N.B; Jeyasekharan, A.D ; Ow, S.G.W; Ho, J; Tan, D.S.P; Lim, J.S.J ; Vijayan, J; Therimadasamy, A.K; Hairom, Z; Ang, E; Ang, S; Thakor, N.V ; Lee, S.-C ; Wilder-Smith, E.P.V 
222020Neoadjuvant therapy in locally advanced colon cancer: A meta-analysis and systematic reviewCheong, C.K.; Nistala, K.R.Y.; Ng, C.H.; Syn, N.; Chang, H.S.Y.; Sundar, R. ; Yang, S.Y.; Chong, C.S. 
2323-Feb-2022Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin +/- Trastuzumab in Advanced Solid TumorsLee, Matilda Xinwei; Wong, Andrea LA ; Ow, Samuel; Sundar, Raghav ; Tan, David SP ; Soo, Ross A ; Chee, Cheng Ean ; Lim, Joline SJ ; Yong, Wei Peng ; Lim, Siew Eng; Goh, Boon Cher ; Wang, Lingzhi ; Lee, Soo Chin 
241-Jun-2022Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast CancerLim, JSJ ; Wong, ALA ; Ow, SGW ; Ngoi, NYL ; Chan, GHJ; Ang, YLE; Chong, WQ; Lim, SE ; Lim, YW; Lee, M; Choo, JRE; Tan, HL; Yong, WP ; Soo, RA ; Tan, DSP ; Chee, CE ; Sundar, R ; Yadav, K ; Jain, S ; Wang, L ; Tai, BC ; Goh, BC ; Lee, SC 
253-Feb-2022Prevention of Oxaliplatin-Induced Peripheral Neuropathy: A Systematic Review and Meta-AnalysisPeng, S; Ying, AF; Chan, NJH; Sundar, R ; Soon, YY; Bandla, A 
262020Profiling of gastric cancer cell-surface markers to achieve tumour-normal discriminationToh, J.; Hoppe, M.M. ; Thakur, T. ; Yang, H. ; Tan, K.T. ; Pang, B. ; Ho, S. ; Roy, R. ; Ho, K.Y.; Yeoh, K.G. ; Tan, P. ; Sundar, R. ; Jeyasekharan, A. 
271-Jun-2019Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapyMolassiotis, A.; Cheng, H.L.; Leung, K.T.; Li, Y.C.; Wong, K.H.; Au, J.S.K.; Sundar, R. ; Chan, A. ; Ng, T.R.D.; Suen, L.K.P.; Chan, C.W.; Yorke, J.; Lopez, V. 
281-Sep-2018Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancerBasu, B; Krebs, MG; Sundar, R ; Wilson, RH; Spicer, J; Jones, R; Brada, M; Talbot, DC; Steele, N; Garces, AH Ingles; Brugger, W; Harrington, EA; Evans, J; Hall, E; Tovey, H; de Oliveira, FM; Carreira, S; Swales, K; Ruddle, R; Raynaud, FI; Purchase, B; Dawes, JC; Parmar, M; Turner, AJ; Tunariu, N; Banerjee, S; de Bono, JS; Banerji, U